ClinicalTrials.gg
CompletedNCT04333043Updated Aug 1, 2024

Hearing Aids Use in Elderly: Efficacy in Speech Perception and in Health-related Quality of Life

An observational study in Hearing Loss, Age-Related, sponsored by Azienda Unita Sanitaria Locale di Piacenza. Completed at 1 site in Italy. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-01.

Sponsored by Azienda Unita Sanitaria Locale di Piacenza · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

Background: Prevalence of hearing loss increases over age; its estimated prevalence is 40-50% in people older than 75 years. Recent studies agree that modification in the hearing threshold contributes to deterioration in sociality, sensitivity, cognition, and quality of life of the elderly subjects.

Our study objective is to verify if rehabilitation with first time applied Hearing Aids (HA) in a cohort of old people with hearing impairment improves over time speech perception in a noisy environment and the overall health-related quality of life.

Methods: The monocentric, prospective, repeated measures, single-subject, clinical observational study will accrue 100 elderly, first-time HA recipients (≥ 65 years). The evaluation protocol is designed to analyze changes on specific measurement tools a year after the first HA fitting in comparison to the evaluation before HA usage.

Evaluations will consist of multiparametric details collected through self-report questionnaires completed by the recipients and a series of commonly used audiometric measures and geriatric assessment tools. The primary indicator of changes in speech perception in noise will be the OLSA test whereas the indicator of changes in overall quality of life will be the AQoL and HHEI questionnaires. Montreal Cognitive Assessment (MoCA) will help us to verify the cognitive state of the subjects. This questionnaire will allow us to exclude a reduction of the cognitive abilities over time.

Discussion: The protocol is designed to make use of measurement tools that have already been applied to the hearing-impaired population in order to compare the effects of HA rehabilitation in the elderly immediately before their first HA usage (Pre) and after gaining 1 year of experience (Post). The broad approach will lead to a greater understanding of how useful hearing influences the quality of life in elderly individuals, and thus improves potentials for healthy aging. Outcomes will be described and analyzed in detail.

Read the detailed description

This study wants to identify significant improvement in speech recognition in noise in elderly patients (>= 65 years) that use HA for the first time and the correlations between the use of the HA and quality of life and cognitive status in elderly patients.

This is a repeated measure, single-subject, prospective observational study. No additional intervention is applied to population of HA recipients. Study subjects who use for the first time unilateral or bilateral hearing aids will be included. Eligible participants are consecutively identified on the HA registry of the Local Unit of the National Health System (NHS). Italian NHS is a welfare system which funds totally or partially the HA costs in selected patients.

An approximate number of 100 individuals will be included. The study design is monocentric and it is conducted at the outpatient service of the ENT Department of the "Saliceto" Hospital.

The test includes language-appropriate materials relative to the participating HA recipient.

The evaluation protocol is designed to coincide with routine clinical visits. Each subject is assessed with the full test-battery and questionnaires that are repeated at each of the two visits: one before the HA fitting (Pre) and one after one year of HA use (Post).

Subjects are enrolled in the clinical investigation only after signing the Patient Informed Consent Form prior to the first assessment (baseline, t0).

During the first assessment (Pre) are carried out this procedures: otoscopy and cleaning of the external auditory canal,- unaided pure tone audiometry, unaided speech audiometry in quiet, Italian version of Oldenburg Satztest (OLSA test) and Montreal Cognitive Assessment (MOCA), Hearing Handicap Inventory in the Elderly Screening test (HHIE-S) and Assessment of Quality of Life (AQoL) questionnaires.

During the second assessment (Post) are carried out: otoscopy and cleaning of the external auditory canal, test of the HA functioning, unaided pure tone audiometry, aided speech audiometry in quiet, Italian version of OLSA test and MOCA, HHIE-S, AQoL and International Outcome Inventory for Hearing Aids (IOI-HA) questionnaires.

The maximum administration time for completion of all measures is estimated to be approximately one hour of which 30 minutes are dedicated to standard self-report forms completed by the HA recipient.

In addition to general healthcare and patient-profile data, a selection of observational clinical assessment tools has been chosen for repeated evaluations to reflect changes in the hearing aid benefit and the overall health status of the elderly individual at post-HA use. These tools are commonly used in audiology and/or geriatric practices and are administered in the appropriate language. All questionnaires are validated for the Italian language.

02

Conditions studied

  • Hearing Loss, Age-Related

Browse trials for

03

In context

Presbycusis

66 studies on the registry are indexed under Presbycusis; 21 are open to participants now.

This study's enrollment of 100 is below the median of 123 across 20 observational studies indexed under Presbycusis.

Browse Presbycusis studies →

Lead sponsor

Azienda Unita Sanitaria Locale di Piacenza is the lead sponsor of 15 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Study subjects who use for the first time unilateral or bilateral hearing aids will be included. Eligible participants are consecutively identified on the HA registry of the Local Unit of the National Health System (NHS). Italian NHS is a welfare system which funds totally or partially the HA costs in selected patients.

Subjects are > = 65 years old people using unilateral or bilateral HA for the first time. According to local NHS threshold-criteria for funding adult's HAs, patients' best ear must have a Pure-Tone Average >= 45 dB HL. Subjects are enrolled in the clinical investigation only after signing the Patient Informed Consent Form prior to the first assessment (baseline, t0). An approximate number of 100 individuals will be included.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age >= 65 years
  • First use of unilateral or bilateral HA
  • HA partially or totally funded by the National Health System
  • Willingness to participate in and to comply with all study procedures
  • Fluency in languages used to assess clinical performance
  • Able to decide on study participation personally, and independently sign their consent

Exclusion criteria

Exclusion Criteria:

  • Unilateral hearing loss
  • Previous use of HA
  • Significantly/severely dependent or fragile
  • Unable to provide consent personally
  • Unable to complete questionnaires for self-assessment independently
  • Significant comorbidities preventing study participation (e.g. blindness, immobility or in a wheelchair, severe aphasia, and other)
  • Unrealistic expectations on the part of the subject regarding the possible benefits, risks and limitations inherent to the procedure and prosthetic device.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (actual)
Patient registry
No

Groups and cohorts

  • Hearing Aids

    Hearing Aids use

    Diagnostic Test: audiological test, cognitive questionnaires

Interventions

  • Diagnostic testaudiological test, cognitive questionnaires

    administration of cognitive and quality of life questionnaires and audiological test

06

What researchers measure

Primary outcomes

  1. Improvement in speech recognition in noise with audiometrical test

    The primary aim is to identify significant improvement in speech recognition in noise in elderly patients (\>= 65 years) that use Hearing Aids for the first time. To verify this aim, our patients are subject to audiometric tests in quiet conditions. Audiometric test include standard threshold measures for frequencies 250-4000 Hz (pure tone audiogram) and speech discrimination (speech audiometry). Normal hearing patients show an average threshold less than 30 dB in the pure tone audiogram. Speech audiometry shows the Speech Reception Threshold (SRT), defined as the level of speech corresponding to 50% of correct answers. Normal hearing patients show a SRT at 30 dB.

    Time frame: up to 12 months

  2. Improvement in speech recognition in noise with OLSA test

    The primary aim is to identify significant improvement in speech recognition in noise in elderly patients (\>= 65 years) that use Hearing Aids for the first time. The primary aim is to identify significant improvement in speech recognition in noise in elderly patients (\>= 65 years) that use Hearing Aids for the first time. To verify this aim, our patients are subject to audiometric tests in noise condition. The audiometric test in noise condition is a speech adaptive audiometry: Italian version of Oldenburg Satztest (OLSA test). The test is conducted using a closed-set response format. Puglisi et al. (2015) described the reference ranges and standard deviations of the OLSA test for the Italian language. The cutoff of the SNR dB (SRT) among the elderly was set to - 0.4 dB based on a reference mean level of -6.7 plus 2 standard deviations. Lower scores underlines a better performances.

    Time frame: up to 12 months

Secondary outcomes

  1. Hearing Aids and quality of life with AQoL-8D questionnaire

    The secondary aim is to process the correlations between the use of the HA and quality of life in elderly. To verify this aim, our patients are subject to this questionnaire: Assessment of Quality of Life (AQoL). The AQoL-8D consists of five psychosocial and three physical dimension. The AQoL includes 35 items with 5 possible answers; this questionnaire does not have a score scale.

    Time frame: up to 12 months

  2. Hearing Aids and cognitive skills with MOCA questionnaire

    The secondary aim is to process the correlations between the use of the HA and cognitive status in elderly. To verify this aim, our patients are subject to this questionnaire: Montreal Cognitive Assessment (MoCA). MoCA detects cognitive impairment. It consisting of 12 subtasks. The total score ranges from 0 (worst performance) to 30 (best performance). The presence of mild cognitive dysfunction is suspected when the final score is less than 26.

    Time frame: up to 12 months

  3. Hearing Aids and cognitive skills and quality of life with IOI-HA questionnaire

    The secondary aim is to process the correlations between the use of the HA and quality of life and cognitive status in elderly. To verify this aim, our patients are subject to this questionnaire: International Outcome Inventory for Hearing Aids (IOI-HA). IOI-HA quantifies the satisfaction of hearing aid users. The IOI-HA contains seven domains used to subjectively evaluate the results of the HA under the following parameters: (1) time for which HA have been used; (2) benefit; (3) residual limitation in daily life activities; (4) satisfaction; (5) residual restrictions to participation; (6) impact on other people; and (7) quality of life. The answers to each question range from poor performance (1) to best performance (5). A high score is an indication of good outcome in aided conditions.

    Time frame: up to 12 months

  4. Hearing Aids and cognitive skills with HHIE-S questionnaire

    The secondary aim is to process the correlations between the use of the HA and cognitive status in elderly. To verify this aim, our patients are subject to this questionnaire: Hearing Handicap Inventory for the Elderly Screening Version (HHIE-S). HHIE-S assess the effects of hearing impairment on emotional and social adjustment in everyday life. This test contains a 10-item questionnaire. The answers to each question range from poor performance (0) to best performance (4). A low HHIE-S total score indicates less perceived difficulties.

    Time frame: up to 12 months

07

Study locations

1 site
  • Ospedale Guglielmo da Saliceto- ENT Department
    Piacenza, PC 29121, Italy
08

References and documents

Publications

  • Cuda D, Ghiselli S, Murri A. Evaluation of the efficacy of hearing aids in older adults: a multiparametric longitudinal study protocol. BMC Geriatr. 2021 Feb 5;21(1):107. doi: 10.1186/s12877-021-02033-z. PubMed 33581722 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Feb 2018 to primary completion in Dec 2023, 70 months.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 26, 2020
First posted
Apr 3, 2020
StartActual
Feb 7, 2018
Primary completionActual
Dec 31, 2023
CompletionActual
Jan 1, 2024
Last update
Aug 1, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04333043
Lead sponsor
Azienda Unita Sanitaria Locale di Piacenza
Responsible party
Sara Ghiselli (Principal investigator, MD, Head of Otolaryngology, PhD student, Azienda Unita Sanitaria Locale di Piacenza) — Principal investigator
First posted
Apr 3, 2020
Start date
Feb 7, 2018
Primary completion
Dec 31, 2023
Completion
Jan 1, 2024
Last update
Aug 1, 2024

Study contacts

Domenico Cuda, MD
principal investigator · Ospedale Guglielmo da Saliceto, Piacenza

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion